ArticleBMC cancer2018

IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.

Wei-Chieh Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.